Additional file 2 of VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status

Bizzaro, Francesca; Fuso Nerini, Ilaria; Taylor, Molly A.; Anastasia, Alessia; Russo, Massimo; Damia, Giovanna; Guffanti, Federica; Guana, Francesca; Ostano, Paola; Minoli, Lucia; Hattersley, Maureen M.; Arnold, Stephanie; Ramos-Montoya, Antonio; Williamson, Stuart C.; Galbiati, Alessandro; Urosevic, Jelena; Leo, Elisabetta; Cavallaro, Ugo; Ghilardi, Carmen; Barry, Simon T.; Bani, Maria Rosa; Giavazzi, Raffaella

doi:10.6084/m9.figshare.16944630.v1

13045_2021_1196_MOESM2_ESM.pdf (402.89 kB)

Additional file 2 of VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status

journal contribution

posted on 2021-11-07, 04:18 authored by Francesca Bizzaro, Ilaria Fuso Nerini, Molly A. Taylor, Alessia Anastasia, Massimo Russo, Giovanna Damia, Federica Guffanti, Francesca Guana, Paola Ostano, Lucia Minoli, Maureen M. Hattersley, Stephanie Arnold, Antonio Ramos-Montoya, Stuart C. Williamson, Alessandro Galbiati, Jelena Urosevic, Elisabetta Leo, Ugo Cavallaro, Carmen Ghilardi, Simon T. Barry, Maria Rosa Bani, Raffaella Giavazzi

Additional file 2. Methods.

Funding

associazione italiana per la ricerca sul cancro

History

Usage metrics

Keywords

Ovarian cancer Patient-derived xenograft PARP inhibitor VEGF pathway inhibitor BRCA Olaparib Cediranib

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2 of VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status

Funding

associazione italiana per la ricerca sul cancro

History

Usage metrics

Categories

Keywords

Licence

Exports